BAC
Bank of America Corporation
BAC has a slight edge over ORI overall, supported by stronger modeled upside and stronger fundamentals.
ORI
Old Republic International Corporation
ORI trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
ORI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
ORI's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like ORI.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over ORI in the historical PE scenario, which offers more potential upside but is not a forecast.
ORI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.2x | $23.06 | -42% |
| Current | 9x | $40.04 | — |
| Fair | 10x | $46.32 | +16% |
| Forward | 13x | $40.04 | — |
| Expensive | 14x | $61.39 | +53% |
Historical ranges are pointers, not guarantees.
ORI's PE is in its cheap range at 9.0x. On analysts' estimates for next year's earnings, today's price would be 13x, in its expensive range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over ORI on the outlook, with more favorable valuation and earnings expectations.
ORI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect ORI's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
ORI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.16 | -29% |
| Q3 2026 | $4.44 | +34% |
| Q2 2026 | $4.56 | +29% |
| Q1 2026 | $4.06 | +32% |
| Q4 2025 | $3.72 | +15% |
| Q3 2025 | $3.32 | -5.4% |
| Q2 2025 | $3.53 | +48% |
| Q1 2025 | $3.07 | +19% |
| Q4 2024 | $3.24 | +54% |
ORI earned $4.44 per share over the past year, up 34% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over ORI on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over ORI on profitability, with a higher operating margin.
ORI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.6B | +5.2% |
| Q2 2026 | $2.5B | +13% |
| Q1 2026 | $2.4B | +14% |
| Q4 2025 | $2.4B | +19% |
| Q3 2025 | $2.4B | +3.5% |
| Q2 2025 | $2.2B | +18% |
| Q1 2025 | $2.1B | +4.9% |
| Q4 2024 | $2B | +3.1% |
ORI's revenue has grown year over year for 11 quarters in a row: $2.6B last quarter, up 5.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | -3.9 points |
| Q2 2026 | 16% | +4.6 points |
| Q1 2026 | 17% | +2.7 points |
| Q4 2025 | 11% | +4.5 points |
| Q3 2025 | 15% | -3.7 points |
| Q2 2025 | 12% | +5.7 points |
| Q1 2025 | 15% | -5.2 points |
| Q4 2024 | 6.5% | -5.7 points |
ORI's operating margin was 11% last quarter, down 3.9 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
ORI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $429.4M | -24% |
| Q2 2026 | $199.7M | +49% |
| Q1 2026 | $281.4M | +21% |
| Q4 2025 | $234.9M | -35% |
| Q3 2025 | $563.9M | +19% |
| Q2 2025 | $133.8M | -43% |
| Q1 2025 | $231.7M | +44% |
| Q4 2024 | $361.7M | +28% |
ORI has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over ORI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
ORI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +431K shares |
| 1 year | -1.8% | -4.6M shares |
| 3 years | -12% | -33.2M shares |
| 5 years | -19% | -56.8M shares |
| Available history | -18% | -54.9M shares |
ORI has 247M diluted shares, down 1.8% from a year ago, with $388M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $112.7M |
| Q2 2026 | $60.2M |
| Q1 2026 | $159.8M |
| Q4 2025 | $55.2M |
| Q3 2025 | $43.3M |
| Q2 2025 | — |
| Q1 2025 | $25.3M |
| Q4 2024 | $174.4M |
ORI spent $388M buying back its own shares over the past year, up 60% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
ORI Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
ORI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.5 | Neutral |
| Stochastic | 35.0 | Neutral |
ORI's weekly RSI is 50 (neutral) and its Stochastic is 35 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
ORI PE vs Financial Services Sector
| Metric | ORI | Sector median | Relative |
|---|---|---|---|
| PE | 9x | 13x | 31% below |
| PE % | 30 | 63 | 33 pts below |
ORI has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
ORI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $38.8 | 3.1% above |
| 20 week MA | $40.7 | 1.6% below |
| 50 week MA | $40.9 | 2% below |
| 100 week MA | $39.7 | 0.9% above |
| 200 week MA | $34.6 | 16% above |
ORI has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over ORI on returns for 2026, with the stronger performance.
ORI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.2 | $19.2 | -14% |
| 2021 | $19.2 | $24.1 | +25% |
| 2022 | $24.1 | $24.3 | +0.7% |
| 2023 | $24.3 | $29.4 | +21% |
| 2024 | $29.4 | $36.4 | +24% |
| 2025 | $36.4 | $46.6 | +28% |
| 2026 YTD | $46.6 | $40.0 | -14% |
ORI has finished higher in five of the last six years. It's down 14% so far in 2026.